TRPC5 and focal segmental glomerulosclerosis: This study did not investigate a role for TRPC5 in this mouse model, but despite the lack of these specific data, the fact that orthogonal approaches continue to implicate TRPC channels in the emergence of FSGS further bolsters the idea that TRPC channels and Ca2+-mediated pathways may be excellent therapeutic targets for a disease that currently lacks effective treatment options.